About this trial
The goal of this clinical trial is to learn if intervention with Landing Place mental health app can support wellness in college students. The main questions it aims to answer are:
Can the app increased well-being in college students? Will the app have increased use and usability by the college students? Researchers will compare two groups of participants to see if the app intervention will increase wellbeing and app usability rates.
Participants will randomly assigned into group 1 and 2. Group 1 will not use the app at all. Group 2 will use the app almost every day for 4 weeks.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Penn State Behrend students
Over the age of 18
Must have an iPhone
Disqualifiers
People outside of Penn State
Minors
People currently in therapy
Trial design
Parallel
Treatments tested in this trial
mental health app
BehavioralThe intervention will be the use of an AI-powered mental health app that includes activities based on evidence-based therapeutic techniques, mindfulness, goal setting, journaling, mood tracking, and educational material. The app is secure, easy-to-use, and customized for the needs of the college students.
Treatment groups
Trial outcomes
Primary outcomes
Well-being related to Attention and Cognitive Functioning
Attention-related symptoms will be assessed using the DSM-5-TR Attention-Deficit/Hyperactivity Disorder and Sluggish Cognitive Tempo Measure, a self-report scale evaluating attentional functioning. Scores vary by subscale, with higher scores indicating greater symptom severity.
Well-being related to Health-related quality of life
Health-related quality of life will be measured using the Medical Outcomes Study Short Form-36 Health Survey (SF-36). The instrument generates domain scores ranging from 0 to 100, with higher scores indicating better perceived health and well-being.
Well-being related to Mental Health Symptom Severity
Mental health symptom severity will be assessed using the Depression Anxiety Stress Scales - 21 Items (DASS-21), a self-report instrument measuring symptoms of depression, anxiety, and stress. Scores range from 0 to 63, with higher scores indicating greater symptom severity.
Well-being related to Functional Impairment
Functional impairment will be evaluated using the Brief Functional Impairment Scale - Long Form (BFIS-LF), which assesses impairment across daily functioning domains. Scores range from 0 to 100, with higher scores indicating greater functional impairment.
Secondary outcomes
Usability
App usability will be assessed using the mHealth App Usability Questionnaire - Standalone Patient App Version (MAUQ-SPA), a self-report instrument designed to evaluate the usability of standalone mHealth applications. Items are rated on a 7-point Likert scale, and total scores range from 1 to 7, with higher scores indicating better perceived usability.
Usage
Patterns of mobile health application use will be assessed using the mHealth Usage Questionnaire, a self-report measure evaluating frequency and duration of app use. Scores are reported in units on a scale, with higher scores indicating greater application use.
Engagement
Engagement with mobile health technology will be measured using the mHealth Technology Use Questionnaire, which assesses overall use and engagement with mHealth technologies. Scores are reported in units on a scale, with higher scores indicating greater technology engagement.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: